Charles Schwab
CEMI

Charles Schwab’s Chembio diagnostics, Inc. CEMI Stock Holding History

Charles Schwab’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41,983
Closed -$148K – 3644
2021
Q1 		$148K Sell
41,983
-7,487
-15% -$41.7K ﹤0.01% 3351
2020
Q4 		$235K Hold
49,470
– – ﹤0.01% 3234
2020
Q3 		$241K Hold
49,470
– – ﹤0.01% 3123
2020
Q2 		$161K Buy
+49,470
New +$470K ﹤0.01% 3196

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Charles Schwab's CEMI Position: Q2 2021 in Review

Charles Schwab sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 41,983 shares — an estimated $148K sold.

Charles Schwab first reported a position in CEMI in Q2 2020 and held it in 4 quarters. The position peaked at $241K in Q3 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Charles Schwab reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Charles Schwab sold 41,983 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $148K.
  • Charles Schwab first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 4 quarters.
  • Charles Schwab's Chembio diagnostics, Inc. position peaked at $241K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.